B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1

Clinical trials for B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 explained in plain language.

Never miss a new study

Get alerted when new B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 trials appear

Sign up with your email to follow new studies for B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for tough blood cancer: trial tests powerful drug cocktail

Disease control Recruiting now

This study is testing a combination of several chemotherapy drugs, with or without an antibody drug, plus a targeted pill called ponatinib. It aims to see if this approach is safe and effective for adults newly diagnosed with a specific, aggressive form of leukemia or lymphoma. T…

Matched conditions: B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1

Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1

Get alerted when new B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 trials appear

New hope for tough blood cancer: trial tests powerful drug cocktail